• Sabra lifted full-year 2026 outlook: net income per diluted share $0.37-$0.39; FFO $1.12-$1.14; normalized FFO $1.53-$1.55.
• AFFO forecast $1.58-$1.6 per diluted share; normalized AFFO $1.59-$1.61, reflecting year-to-date performance, transactions completed by July 21, 2026.
• Guidance incorporates planned re-tenanting of 26 Avamere-leased properties, targeting $53 million annualized cash rent versus $41 million in the prior 12 months.
• Also assumes over $9 million annual run-rate cash NOI uplift from smaller initiatives, largely closed, with remaining deals expected in 2H 2026.
• Outlook reflects RCA mortgage payoff at $200 million versus $300 million face value, cutting net debt/EBITDA to 4.8x from 5.0x pro forma.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sabra Health Care REIT Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202607210905BIZWIRE_USPR_____20260721_BW768789) on July 21, 2026, and is solely responsible for the information contained therein.